Bruker EPS - Earnings per Share 2012-2026 | BRKR
Bruker annual and quarterly earnings per share history from 2012 to 2026. Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
- Bruker EPS for the quarter ending March 31, 2026 was $0.02, a 81.82% decline year-over-year.
- Bruker EPS for the twelve months ending March 31, 2026 was $-0.24, a 146.15% decline year-over-year.
- Bruker 2025 annual EPS was $-0.15, a 119.74% decline from 2024.
- Bruker 2024 annual EPS was $0.76, a 73.79% decline from 2023.
- Bruker 2023 annual EPS was $2.9, a 45.73% increase from 2022.
| Bruker Annual EPS | |
|---|---|
| 2025 | $-0.15 |
| 2024 | $0.76 |
| 2023 | $2.90 |
| 2022 | $1.99 |
| 2021 | $1.81 |
| 2020 | $1.02 |
| 2019 | $1.26 |
| 2018 | $1.14 |
| 2017 | $0.49 |
| 2016 | $0.95 |
| 2015 | $0.60 |
| 2014 | $0.33 |
| 2013 | $0.48 |
| 2012 | $0.46 |
| 2011 | $0.55 |
| Bruker Quarterly EPS | |
|---|---|
| 2026-03-31 | $0.02 |
| 2025-12-31 | $0.10 |
| 2025-09-30 | $-0.41 |
| 2025-06-30 | $0.05 |
| 2025-03-31 | $0.11 |
| 2024-12-31 | $0.09 |
| 2024-09-30 | $0.27 |
| 2024-06-30 | $0.05 |
| 2024-03-31 | $0.35 |
| 2023-12-31 | $1.39 |
| 2023-09-30 | $0.60 |
| 2023-06-30 | $0.39 |
| 2023-03-31 | $0.52 |
| 2022-12-31 | $0.66 |
| 2022-09-30 | $0.59 |
| 2022-06-30 | $0.33 |
| 2022-03-31 | $0.41 |
| 2021-12-31 | $0.49 |
| 2021-09-30 | $0.57 |
| 2021-06-30 | $0.38 |
| 2021-03-31 | $0.37 |
| 2020-12-31 | $0.44 |
| 2020-09-30 | $0.35 |
| 2020-06-30 | $0.16 |
| 2020-03-31 | $0.07 |
| 2019-12-31 | $0.44 |
| 2019-09-30 | $0.39 |
| 2019-06-30 | $0.23 |
| 2019-03-31 | $0.20 |
| 2018-12-31 | $0.49 |
| 2018-09-30 | $0.28 |
| 2018-06-30 | $0.20 |
| 2018-03-31 | $0.17 |
| 2017-12-31 | $-0.02 |
| 2017-09-30 | $0.23 |
| 2017-06-30 | $0.15 |
| 2017-03-31 | $0.13 |
| 2016-12-31 | $0.43 |
| 2016-09-30 | $0.29 |
| 2016-06-30 | $0.09 |
| 2016-03-31 | $0.14 |
| 2015-12-31 | $0.36 |
| 2015-09-30 | $0.07 |
| 2015-06-30 | $0.13 |
| 2015-03-31 | $0.04 |
| 2014-12-31 | $0.15 |
| 2014-09-30 | $0.03 |
| 2014-06-30 | $0.10 |
| 2014-03-31 | $0.05 |
| 2013-12-31 | $0.21 |
| 2013-09-30 | $0.10 |
| 2013-06-30 | $0.14 |
| 2013-03-31 | $0.03 |
| 2012-12-31 | $0.07 |
| 2012-09-30 | $0.24 |
| 2012-06-30 | $0.06 |
| 2012-03-31 | $0.09 |
| 2011-12-31 | $0.23 |
| 2011-09-30 | $0.12 |
| 2011-06-30 | $0.13 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Computer and Technology | Scientific Instruments Manufacturing | $5.722B | $3.437B |
| Bruker Corp designs & manufactures proprietary life science & materials research systems & associated products that serve multiple customers in life science research, pharmaceuticals, applied markets, nanotechnology, cell biology, clinical research, microbiology & in-vitro diagnostics. BSI Life Science reports under two groups: Bruker BioSpin Group & Bruker CALID Group. The Bruker BioSpin comprises the Bruker Magnetic Resonance & Preclinical Imaging divisions, which designs, manufactures & distributes enabling life science tools based on the magnetic resonance technology. The Bruker CALID comprises the Bruker Daltonics & primarily designs, manufactures & distributes life-science mass spectrometry instruments that can be integrated with other sample preparation or chromatography instruments. BSI Nano designs, manufactures & distributes advanced X-ray instruments to determine the characteristics of matter & the three-dimensional structure of molecules. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kewaunee Scientific (KEQU) | United States | $0.100B | 8.24 |
| Harvard Bioscience (HBIO) | United States | $0.019B | 0.00 |